New approach to HIV prevention for LGBTQ+ substance users falls short
NCT ID NCT05934877
First seen Feb 18, 2026 · Last updated May 24, 2026 · Updated 12 times
Summary
This study aimed to help HIV-negative transgender women and men who have sex with men who also have a substance use disorder stick with PrEP (HIV prevention medication). Participants were given counseling and text support, with extra help for those struggling. The study was terminated early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Friends Community Center
Los Angeles, California, 90038, United States
Conditions
Explore the condition pages connected to this study.